Evidence map›Paper›PMID 22506081›Full record

ArticlePLoS neglected tropical diseases2012

Multiple mitochondrial introgression events and heteroplasmy in trypanosoma cruzi revealed by maxicircle MLST and next generation sequencing.

Louisa A Messenger, Martin S Llewellyn, Tapan Bhattacharyya, Oscar Franzén, Michael D Lewis, Juan David Ramírez, Hernan J Carrasco, Björn Andersson, Michael A Miles

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 127 citations in OpenAlex.

  1. Mitochondrial DNA Structure inPathogens (Basel, Switzerland) · 2025
    Review
  2. Article
  3. New insights intoFrontiers in immunology · 2024
    Review
  4. Fifteen Years after the Definition ofLife (Basel, Switzerland) · 2023
    Review
  5. Article
  6. Macrophage-infectivity potentiator ofFrontiers in immunology · 2023
    Article
  7. Article
  8. Genetic Diversity ofMicroorganisms · 2022
    Article
  9. Article
  10. Article
  11. AssessingPathogens (Basel, Switzerland) · 2021
    Article
  12. The Complete Mitochondrial DNA ofFrontiers in cellular and infection microbiology · 2021
    Article
  13. Article
  14. Genes · 2020
    Review
  15. Tropical medicine and infectious disease · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Louisa A MessengerDepartment of Pathogen Molecular Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom. louisa.messenger@lshtm.ac.uk
Martin S Llewellyn
Tapan Bhattacharyya
Oscar Franzén
Michael D Lewis
Juan David Ramírez
Hernan J Carrasco
Björn Andersson
Michael A Miles
London School of Hygiene & Tropical Medicine · GBCentral University of Venezuela · VEKarolinska Institutet · SEScience for Life Laboratory · SEUniversidad de Los Andes · CO

Funding

Biotechnology and Biological Sciences Research CouncilWellcome Trust
6 · The paper itself

Abstract

backgroundMitochondrial DNA is a valuable taxonomic marker due to its relatively fast rate of evolution. In Trypanosoma cruzi, the causative agent of Chagas disease, the mitochondrial genome has a unique structural organization consisting of 20-50 maxicircles (∼20 kb) and thousands of minicircles (0.5-10 kb). T. cruzi is an early diverging protist displaying remarkable genetic heterogeneity and is recognized as a complex of six discrete typing units (DTUs). The majority of infected humans are asymptomatic for life while 30-35% develop potentially fatal cardiac and/or digestive syndromes. However, the relationship between specific clinical outcomes and T. cruzi genotype remains elusive. The availability of whole genome sequences has driven advances in high resolution genotyping techniques and re-invigorated interest in exploring the diversity present within the various DTUs. METHODOLOGY/PRINCIPAL

findingsTo describe intra-DTU diversity, we developed a highly resolutive maxicircle multilocus sequence typing (mtMLST) scheme based on ten gene fragments. A panel of 32 TcI isolates was genotyped using the mtMLST scheme, GPI, mini-exon and 25 microsatellite loci. Comparison of nuclear and mitochondrial data revealed clearly incongruent phylogenetic histories among different geographical populations as well as major DTUs. In parallel, we exploited read depth data, generated by Illumina sequencing of the maxicircle genome from the TcI reference strain Sylvio X10/1, to provide the first evidence of mitochondrial heteroplasmy (heterogeneous mitochondrial genomes in an individual cell) in T. cruzi. CONCLUSIONS/SIGNIFICANCE: mtMLST provides a powerful approach to genotyping at the sub-DTU level. This strategy will facilitate attempts to resolve phenotypic variation in T. cruzi and to address epidemiologically important hypotheses in conjunction with intensive spatio-temporal sampling. The observations of both general and specific incidences of nuclear-mitochondrial phylogenetic incongruence indicate that genetic recombination is geographically widespread and continues to influence the natural population structure of TcI, a conclusion which challenges the traditional paradigm of clonality in T. cruzi.

Indexed as

Genetic VariationCluster AnalysisDNA, CircularDNA, MitochondrialGenotypeHigh-Throughput Nucleotide SequencingHumansMitochondriaMolecular Sequence DataMultilocus Sequence TypingPhylogenyRecombination, GeneticTrypanosoma cruziDNA, CircularDNA, Mitochondrial

Identifiers

PMID22506081
PMCPMC3323513
OpenAlexW2059134652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.